Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Rangering i aksjer #2096
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Aksjekurs
$142.09
Markedsverdi
$9.85B
Endring (1 dag)
-0.39%
Endring (1 år)
-56.81%
Land
US
Handel Insulet Corp. (PODD)

Kategori

Healthcare
Aksjeprishistorikk for Insulet Corp. (PODD)
Høyeste sluttskurs: $137.02 den 2026-10-01

Laveste sluttskurs: $15.32 den 2007-05-01
Aksjeprishistorikk for Insulet Corp. fra 2007 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -28.61%
2025 10.94%
2024 29.28%
2023 -31.55%
2022 12.13%
2021 7.15%
2020 41.98%
2019 122.73%
2018 14.06%
2017 87.47%
2016 -0.45%
2015 -18.45%
2014 23.64%
2013 70.93%
2012 17.30%
2011 23.42%
2010 14.55%
2009 83.92%
2008 -70.52%
2007 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$100.56 -21.15%
US
$93.07 -2.88%
IE
$297.13 -21.76%
US
$44.47 -55.49%
US
$46.69 -17.17%
DE